Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)

Brad A. Racette; Mikula Stambuk; Joel S. Perlmutter

doi:10.1002/mds.10209

Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)

Brad A. Racette, Mikula Stambuk, Joel S. Perlmutter

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.

Original language	English
Pages (from-to)	1098-1100
Number of pages	3
Journal	Movement Disorders
Volume	17
Issue number	5
DOIs	https://doi.org/10.1002/mds.10209
State	Published - Sep 2002

Keywords

Botulinum toxin A
Secondary resitance

Access to Document

10.1002/mds.10209

Cite this

@article{0124f53cd433414eaa72839e503a4966,

title = "Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)",

abstract = "We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.",

keywords = "Botulinum toxin A, Secondary resitance",

author = "Racette, {Brad A.} and Mikula Stambuk and Perlmutter, {Joel S.}",

year = "2002",

month = sep,

doi = "10.1002/mds.10209",

language = "English",

volume = "17",

pages = "1098--1100",

journal = "Movement Disorders",

issn = "0885-3185",

number = "5",

}

TY - JOUR

T1 - Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)

AU - Racette, Brad A.

AU - Stambuk, Mikula

AU - Perlmutter, Joel S.

PY - 2002/9

Y1 - 2002/9

N2 - We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.

AB - We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.

KW - Botulinum toxin A

KW - Secondary resitance

UR - http://www.scopus.com/inward/record.url?scp=0036764845&partnerID=8YFLogxK

U2 - 10.1002/mds.10209

DO - 10.1002/mds.10209

M3 - Article

C2 - 12360571

AN - SCOPUS:0036764845

SN - 0885-3185

VL - 17

SP - 1098

EP - 1100

JO - Movement Disorders

JF - Movement Disorders

IS - 5

ER -

Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this